Alzamend Neuro Inc.
1.16
0.03 (2.65%)
At close: Jan 15, 2025, 10:54 AM

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
Revenue n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue 50.74K 23.07K n/a n/a n/a n/a n/a n/a n/a
Gross Profit -50.74K -23.07K n/a n/a n/a n/a n/a n/a n/a
Operating Income -9.94M -14.87M -12.32M -4.95M -4.42M -5.01M -898.43K -1.55M -69.46K
Interest Income n/a 7.70 46.52 1.71K 13.93K 146.39K 33.23K 21.50K n/a
Pretax Income -9.95M -14.88M -12.36M -5.05M -4.41M -4.86M -931.66K -1.57M -69.46K
Net Income -9.95M -14.88M -12.40M -5.20M -4.40M -4.86M -931.66K -1.57M -69.46K
Selling & General & Admin 3.48M 7.42M 7.12M 3.64M 3.35M 1.31M 575.03K 1.27M 69.46K
Research & Development 6.46M 7.45M 5.20M 1.31M 1.07M 3.70M 323.40K 275.05K n/a
Other Expenses 0.00 n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses 9.94M 14.87M 12.32M 4.95M 4.42M 5.01M 898.43K 1.55M 69.46K
Interest Expense 10.10K 7.70K 46.52K 158.80K n/a n/a n/a n/a n/a
Selling & Marketing Expenses 247.33K 742.60K 17.65K n/a n/a n/a 29.91K 330.84K n/a
Cost & Expenses 9.94M 14.87M 12.32M 4.95M 4.42M 5.01M 898.43K 1.55M 69.46K
Income Tax n/a -144.83K 42.52K 157.10K -13.93K -146.39K -898.43K -21.50K n/a
Shares Outstanding (Basic) 676.00K 650.00K 593.00K 484.00K 475.00K 392.00K 568.70K 192.00K 165.00K
Shares Outstanding (Diluted) 676.57K 650.13K 593.97K 484.33K 475.02K 392.29K 568.70K 192.01K 165.30K
EPS (Basic) -14.72 -22.89 -20.92 -10.75 -9.26 -12.4 -1.64 -8.18 -0.42
EPS (Diluted) -14.7 -22.89 -20.88 -10.74 -9.25 -12.4 -1.64 -8.18 -0.42
EBITDA -9.89M -14.85M -12.32M n/a n/a n/a 7.34K -21.50K n/a
Depreciation & Amortization 50.74K 23.07K 3.55K 4.95M 4.42M 5.01M 898.43K 1.55M 69.46K

Create Price Alert on ALZN

Your price alert will notify you when the stock price is above 1.16.

Add to Watchlist